glp-1 cardiovascular outcome trials Cardiovascular, mortality, and kidney outcomes with receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised GLP-1RAs reduce cardiovascular deaths in

glp-1 cardiovascular outcome trials

glp-1 cardiovascular outcome trials Cardiovascular, mortality, and kidney outcomes with receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised GLP-1RAs reduce cardiovascular deaths in

Name: glp-1 cardiovascular outcome trials Cardiovascular, mortality, and kidney outcomes with receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised GLP-1RAs reduce cardiovascular deaths in
Brand: inesschwebach.de
SKU: 54394387538
Price: 27.05 USD
Availability: InStock
Rating: 4.4743 (13 reviews)

SKU: 54394387538

4.5

EUR27.05 EUR57.05

Pay in 4 interest-free payments of $6.76 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Sep 13 - Sep 18

Description

36,37,38 Different GLP-1RA use between studies may contribute to inconsistent findings across the studies

Future studies should investigate whether p53 ablation in adipocytes, with concomitant reduction in the abundance of AT macrophages, might lead to differences in weight (re-)gain after return to normal or obesogenic diet, to further test the hypothesis that adipocyte p53 is key in establishing an immuno-obesogenic memory of AT that promotes weight regain